Company NovaBay Pharmaceuticals, Inc.

Equities

NBY

US66987P4090

Biotechnology & Medical Research

Market Closed - Nyse 21:00:00 14/06/2024 BST 5-day change 1st Jan Change
2.51 USD -2.33% Intraday chart for NovaBay Pharmaceuticals, Inc. -7.38% -64.85%

Business Summary

NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. It also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.

Number of employees: 25

Sales per Business

USD in Million2022Weight2023Weight Delta
Eyecare & Wound Care
75.9 %
10 71.1 % 11 75.9 % +9.13%
Skincare
24.1 %
4 28.9 % 4 24.1 % -14.72%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
14 100.0 % 15 100.0 % +2.24%

Managers

Managers TitleAgeSince
Chief Executive Officer 46 31/01/13
Director of Finance/CFO 38 30/11/19

Members of the board

Members of the board TitleAgeSince
Chairman 89 30/04/02
Director/Board Member 67 10/09/19
Director/Board Member 49 25/01/16
Chief Executive Officer 46 31/01/13
Director/Board Member 53 26/01/22
Director/Board Member 46 16/12/19
Director/Board Member 54 26/01/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,000 0 0 99.97 %
Stock B 1 1,151,715 1,151,399 ( 99.97 %) 0
Stock C 0 1,000 0 0

Shareholders

NameEquities%Valuation
UBS Securities LLC
0.6119 %
6,304 0.6119 % 21 686 $
Two Sigma Securities LLC
0.4141 %
4,266 0.4141 % 14 675 $
Geode Capital Management LLC
0.0695 %
716 0.0695 % 2 463 $
Tower Research Capital LLC
0.0422 %
435 0.0422 % 1 496 $
Vanguard Group, Inc. (Subfiler)
0.0380 %
392 0.0380 % 1 348 $
Zacks Investment Management, Inc.
0.0278 %
286 0.0278 % 984 $
Justin Hall
0.006600 %
68 0.006600 % 234 $
Paul Freiman
0.004950 %
51 0.004950 % 175 $
Yen You Zheng
0.004756 %
49 0.004756 % 169 $
Swan Sit
0.004756 %
49 0.004756 % 169 $

Company contact information

NovaBay Pharmaceuticals, Inc.

2000 Powell Street Suite 1150

94608-1866, Emeryville

+510 899 8800

http://www.novabay.com
address NovaBay Pharmaceuticals, Inc.(NBY)
  1. Stock Market
  2. Equities
  3. NBY Stock
  4. Company NovaBay Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW